Celldex Therapeutics (CLDX)
(Delayed Data from NSDQ)
$35.28 USD
+0.17 (0.48%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $35.25 -0.03 (-0.09%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Celldex Therapeutics, Inc. [CLDX]
Reports for Purchase
Showing records 101 - 120 ( 412 total )
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2Q18 Results; Building Differentiated Asset Profiles
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Varlilumab Nivolumab Combination Heating up Advanced Tumors
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
1Q18 Results; Reset in Place With New Priorities; Target Adjusted to $2.15
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
METRIC Gets Dinged as We Now Look Toward Outcome of Strategic Review; Target Reduced to $2.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2017 Results; The Anticipation for METRIC Is Palpable
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Sleeper Shall Awaken; Awaiting a Much Needed Share Boost From METRIC
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Celldex Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
3Q17 Results; Things Remain Busy at CLDX; Eyes Toward METRIC; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J